FDA inspection
Pierre Fabre Medicament: FDA inspection ending Apr 15, 2016
FDA inspection 970600 · Voluntary Action Indicated (VAI) · Gaillac
Key facts
| Inspection ID | 970600 |
|---|---|
| Firm | Pierre Fabre Medicament |
| FEI number | 3002807889 |
| Address | Zone Industrielle de Clergous, 16 rue Jean Rostand |
| City | Gaillac |
| Country | France |
| Fiscal year | 2016 |
| Inspection end date | Apr 15, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data